Yulia Nam

Yulia Nam

Auto-generated profile, based on publicly available information

Yulia Nam

Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2025 in Ophthalmology Glaucoma
Verified
Journal Article
Open access
NHNatalie R. Hamilton
Natalie R. Hamilton
AAAnam Akhlaq
Anam Akhlaq
PNPatrick O. Nnoromele
Patrick O. Nnoromele
NGNicolas Gasquet
Nicolas Gasquet
CGCatalina Garzon
Catalina Garzon
TJThomas Johnson
Thomas Johnson
To assess the clinical outcomes of Hydrus Microstent implantation with cataract extraction for the treatment of open angle glaucoma (OAG) over a maximum of 4 years. Retrospective, single-center, single-arm, longitudinal cohort study. 308 patients (464 eyes) with OAG who underwent Hydrus Microstent implantation with cataract extraction between February 2019 and December 2021, followed for a median (interquartile range, IQR) of 2.0 (1.3, 2.8) years. Medical records were reviewed to collect demographic and clinical data. After assessment for Gaussian distribution, mean and standard deviation (SD) or median and IQR were calculated. Change from baseline was calculated with mixed-effects models and expressed as mean change and standard error (SE). 1) Intraocular pressure (IOP); 2) number of glaucoma medications; 3) need for additional glaucoma procedures; and 4) rate of glaucoma progression, calculated using mean deviation (MD) from standard automated perimetry and optical coherence tomography peripapillary retinal nerve fiber layer (RFNL) thickness. Among 308 patients, 60.7% (n=187) were White and 50.6% (n=156) were female. The median (IQR) age was 74 (68, 78) years. Most eyes had mild (63.8%) or moderate (23.9%) OAG. Of 464 eyes, 99 (21.4%) had undergone prior procedures for glaucoma. At baseline, the mean (±SD) IOP was 16.0±3.7 mmHg while taking 1.9±1.1 glaucoma medications. After Hydrus implantation, a sustained reduction was observed in mean IOP [mean change±SE]: -1.9±0.3 at 6 months (p<0.0001), -1.2±0.2 at 1 year (p<0.0001), -1.2±0.2 at 2 years (p<0.0001), -1.6±0.3 at 3 years (p<0.0001) and -1.2±0.7 at 4 years (p=0.02)]. Glaucoma medications were reduced by 1.2±0.1 at 6 months (p<0.0001), 1.1±0.1 at 1 year (p<0.0001), 1.0±0.1 at 2 years (p<0.0001), 0.9±0.1 at 3 years (p<0.0001) and 0.5±0.2 at 4 years (p=0.03). Only 14 eyes (3.2%) required additional glaucoma procedures. Compared to the lookback period, the rates of visual field MD and RNFL loss decreased in the postoperative period by 0.18±0.08 dB/year (-0.18±0.02 vs 0.004±0.08 dB/year, p=0.02) and 0.51±0.29 μm/year (-0.47±0.12 vs 0.04±0.21 μm/year, p=0.07), respectively. In this non-trial setting, cataract surgery with Hydrus Microstent implantation was associated with sustained reductions in IOP, glaucoma medication burden, and disease progression rate.

19 May 2026 in Ophthalmology Glaucoma
Verified
Journal Article
Open access
JSJasdeep Sabharwal
Jasdeep Sabharwal
MTMargaret Tharp
Margaret Tharp
NHNatalie Hamilton
Natalie Hamilton
YNYulia Nam
Yulia Nam
MPMaria Catalina Pizarro Penaranda
Maria Catalina Pizarro Penaranda
TJThomas Johnson
Thomas Johnson
To characterize the time to maximum intraocular pressure (IOP) change after stopping and restarting topical prostaglandin analog (PGA) treatment using remote tonometry. Prospective single-site observational study. Patients with primary open-angle glaucoma or ocular hypertension treated with ≥ 4 weeks of PGA monotherapy, in whom the managing ophthalmologist ordered medication washout to assess the necessity of continued topical therapy. Patients used a rebound home tonometer to obtain ≥4 daily measurements across 3 periods: "Baseline" (1 week while continuing PGA), "Washout" (4 weeks off therapy), and "Restart" (4 weeks while restarting PGA). Exponential decay functions were used to model IOP from "Baseline" through "Washout" and then from end of "Washout" through "Restart" to determine the time to 90% of maximum IOP change (plateau, T90%%). We evaluated the variation in T90% using multilevel models to account for the inclusion of both eyes from individual subjects. T90% for "Washout" and "Restart" RESULTS: 20 subjects (34 eyes) successfully recorded multiple daily eye measurements for the 9-week study period. Mean (SD) IOPs during the "Baseline", "Washout", and "Restart" periods were 15.6 (4.2) mmHg, 17.3 (5.0) mmHg, and 15.9 (4.4) mmHg, respectively. "Baseline" and "Restart" IOPs were significantly lower than "Washout" IOP (p < 0.001). T90% was significantly longer and more variable among subjects during Washout (median: 18.5 days; IQR 6.0-32.1 days) compared to Restart (2.2 days; 1.3-4.1 days, p < 0.001). Using remote tonometry, we identified a significantly longer T90% after stopping PGA drops than when they were restarted. The ranges of time to reach the IOP plateau were wide, often exceeding the standardized 4-week washout, and are relevant to clinical assessment of routine treatment effects and determination of accurate washout periods for clinical research studies.

3 November 2026 in Ophthalmology
Verified
Journal Article
Open access
MJMichael Seth Jensen
Michael Seth Jensen
ARAndy W. Renschler
Andy W. Renschler
CJCatherine Johnson
Catherine Johnson
CSCoy M. Steel
Coy M. Steel
DEDevin Eddington
Devin Eddington
BWBarbara M. Wirostko
Barbara M. Wirostko

22 September 2022 in Russian Ophthalmological Journal
Verified
Journal Article
Open access
PDF file
LML. K. Moshetova
L. K. Moshetova
IAI. B. Alekseev
I. B. Alekseev
IVIrina Vorobyeva
Irina Vorobyeva
YNYu. A. Nam
Yu. A. Nam
Purpose: an analysis of clinical and morphofunctional changes of the retina in high myopia combined with age-related macular degeneration (AMD) of various stages.Materials and methods. We examined 45 patients (87 eyes, mean age 60 years) with high myopia (ave. spherical equivalent (SE) of refraction -11.0 D [-15.0; -7.125]) and the “dry” form of AMD, categories AREDS 1, 2, 3. Additionally, we formed three control groups of the same age range: group 1 consisted of 30 healthy subjects (58 eyes) with a SE between -0.25 D and +0.5 D and no retinal changes; group 2 included 20 patients (38 eyes) with isolated high myopia (SE +0.5 D and no retinal changes; group 2 included 20 patients (38 eyes) with isolated high myopia (SE ³ 6.5 D) and group 3 included another 20 patients (36 eyes) with the “dry” AMD form (AREDS 2, 3). We evaluated the best corrected visual acuity (BCVA), indicators of retinal photosensitivity (MD, PSD) according to computer perimetry data, and morphological characteristics: central retinal thickness (CRT), the anteroposterior axis of the eyeball, the condition of the macular region of the retina according to optical coherence tomography (OCT) in the β-scan mode and autofluorescence (AF).Results: in case of the combined pathology, we detected a reliable reduction of average BCVA to the level of 0.5 [0.3; 0.7] (p < 0.001) and a reduced factor of retinal photosensitivity as compared to the control: MD to -4.36 dB (р<0.001), PSD to 2.97 dB (р < 0.001). CRT was 235 μm (p = 0.122), which showed no statistically significant differences to the control. Morphological changes of the retina corresponded to high myopia and AMD: a dome-shaped profile, lacquer cracks, paravascular retinal microcysts, paravascular lamellar ruptures; myopic maculopathy in the form of an epiretinal membrane, vitreomacular traction due to incomplete vitreoretinal cleavage, myopic foveoshisis; patchy chorioretinal atrophy, areas of diffuse RPE atrophy, damage of the junction line of the outer and inner segments of photoreceptors. The increase in the number and size of drusen depended on the stage of AMD. Normal autofluorescence of the fundus was absent. Pathological AF included minimal changes patterned as focal hypo- and hyperautofluorescence, reticular pattern, focal pattern, linear pattern, lace-like pattern, areas of geographic atrophy with pronounced hypoautofluorescence.Conclusion. Changes in OCT and visual field parameters (MD, PSD) in comorbid pathology (AMD combined with high myopia) were revealed. The morphofunctional indicators were compared for different AMD stages, and the diagnostic significance of AF was established.

30 September 2026 in Ophthalmology
Verified
Journal Article
Open access
MPMaria C. Pizarro Peñaranda
Maria C. Pizarro Peñaranda
AMAleksandra Mihailovic
Aleksandra Mihailovic
SCShashi Chaudhary
Shashi Chaudhary
NHNatalie Hamilton
Natalie Hamilton
YNYulia Nam
Yulia Nam
TJThomas Johnson
Thomas Johnson